A clinical trial of avapritinib versus regorafenib (Stivarga®) for people with advanced GIST that has progressed following first-line treatment with imatinib (Gleevec®) and one or two additional treatment regimens (third-line or fourth-line GIST).
Guangxi Medical University is an undergraduate clinical medicine program approved by the Ministry of Education. One of the first batch of 30 students university qualifications, Guangxi Zhuang focuses on the construction of three disciplines under one university: medical education, medical research, and clinical and preventive health care.
Nanning, China Clinical Trial Location
Guangxi Medical University Affiliated Tumor Hospital & Oncology Medical College
22 Shuangyong Rd, Qingxiu District,
Nanning, Guangxi, China